1.Coil Embolization for Supra-annular Rupture During Transcatheter Aortic Valve Replacement Under Extracorporeal Membrane Oxygenation Support
Hee Jeong LEE ; In-Cheol KIM ; Hyoung-Seob PARK ; Woo Sung JANG ; Jae Bum KIM ; Jin Young KIM ; Seung-Ho HUR ; Cheol Hyun LEE
Korean Circulation Journal 2022;52(2):166-168
no abstract available.
2.Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin
Hundo CHO ; Jin-Hyuk CHOI ; Seok Yun KANG ; Hyun Woo LEE ; Yong Won CHOI ; Tae-Hwan KIM ; Mi Sun AHN ; Chul-Ho KIM ; Yoo Seob SHIN ; Jeon Yeob JANG ; Young-Taek OH ; Jaesung HEO ; Seung Soo SHEEN
The Korean Journal of Internal Medicine 2022;37(3):653-659
Background/Aims:
The study investigated the incidence of thromboembolic events (TEE) in head and neck (H&N) cancer patients who received concurrent chemoradiotherapy (CCRT) with cisplatin, and analyzed the factors affecting TEE occurrence
Methods:
Two hundred and fifty-seven patients who started CCRT with cisplatin for H&N cancer from January 2005 to December 2019 were analyzed.
Results:
TEE occurred in five patients, an incidence rate of 1.9%. The 2-, 4-, and 6-month cumulative incidences of TEE were 0.8%, 1.6%, and 1.9%, respectively. Khorana score was the only factor associated with TEE occurrence (p = 0.010).
Conclusions
The incidence of TEE in H&N cancer patients who underwent CCRT with cisplatin was relatively low when compared to other types of cancer. However, patients with a high Khorana score require more careful surveillance for possible TEE occurrence.
3.Analysis of thromboembolic events in head and neck cancer patients who underwent concurrent chemoradiotherapy with cisplatin
Hundo CHO ; Jin-Hyuk CHOI ; Seok Yun KANG ; Hyun Woo LEE ; Yong Won CHOI ; Tae-Hwan KIM ; Mi Sun AHN ; Chul-Ho KIM ; Yoo Seob SHIN ; Jeon Yeob JANG ; Young-Taek OH ; Jaesung HEO ; Seung Soo SHEEN
The Korean Journal of Internal Medicine 2022;37(6):1269-
4.Serotype Distribution and Antimicrobial Resistance of Invasive and Noninvasive Streptococcus pneumoniae Isolates in Korea between 2014 and 2016
Dong Chul PARK ; Si Hyun KIM ; Dongeun YONG ; In Bum SUH ; Young Ree KIM ; Jongyoun YI ; Wonkeun SONG ; Sae Am SONG ; Hee Won MOON ; Hae Kyung LEE ; Kyoung Un PARK ; Sunjoo KIM ; Seok Hoon JEONG ; Jaehyeon LEE ; Joseph JEONG ; Yu Kyung KIM ; Miae LEE ; Jihyun CHO ; Jong Wan KIM ; Kyeong Seob SHIN ; Sang Hyun HWANG ; Jae Woo CHUNG ; Hye In WOO ; Chae Hoon LEE ; Namhee RYOO ; Chulhun L CHANG ; Hyun Soo KIM ; Jayoung KIM ; Jong Hee SHIN ; Soo Hyun KIM ; Mi Kyung LEE ; Seong Gyu LEE ; Sook Jin JANG ; Kyutaeg LEE ; HunSuk SUH ; Yong Hak SOHN ; Min Jung KWON ; Hee Joo LEE ; Ki Ho HONG ; Kwang Sook WOO ; Chul Min PARK ; Jeong Hwan SHIN
Annals of Laboratory Medicine 2019;39(6):537-544
BACKGROUND: Several factors contribute to differences in Streptococcus pneumoniae serotype distribution. We investigated the serotype distribution and antimicrobial resistance of S. pneumoniae isolated between 2014 and 2016 in Korea. METHODS: We collected a total of 1,855 S. pneumoniae isolates from 44 hospitals between May 2014 and May 2016, and analyzed the serotypes by sequential multiplex PCR. We investigated the distribution of each serotype by patient age, source of the clinical specimen, and antimicrobial resistance pattern. RESULTS: The most common serotypes were 11A (10.1%), followed by 19A (8.8%), 3 (8.5%), 34 (8.1%), 23A (7.3%), and 35B (6.2%). The major invasive serotypes were 3 (12.6%), 19A (7.8%), 34 (7.8%), 10A (6.8%), and 11A (6.8%). Serotypes 10A, 15B, 19A, and 12F were more common in patients ≤5 years old, while serotype 3 was more common in patients ≥65 years old compared with the other age groups. The coverage rates of pneumococcal conjugate vaccine (PCV)7, PCV10, PCV13, and pneumococcal polysaccharide vaccine 23 were 11.8%, 12.12%, 33.3%, and 53.6%, respectively. Of the 1,855 isolates, 857 (46.2%) were multi-drug resistant (MDR), with serotypes 11A and 19A predominant among the MDR strains. The resistance rates against penicillin, cefotaxime, and levofloxacin were 22.8%, 12.5%, and 9.4%, respectively. CONCLUSIONS: There were significant changes in the major S. pneumoniae serotypes in the community. Non-PCV13 serotypes increased in patients ≤5 years old following the introduction of national immunization programs with the 10- and 13-polyvalent vaccines.
Cefotaxime
;
Humans
;
Immunization Programs
;
Korea
;
Levofloxacin
;
Multiplex Polymerase Chain Reaction
;
Penicillins
;
Pneumococcal Vaccines
;
Pneumonia
;
Serogroup
;
Streptococcus pneumoniae
;
Streptococcus
;
Vaccines
5.Correction of Cicatricial Upper Eyelid Ectropion Using a Dermofat Graft and an Anti-Adhesive Agent
Suk Yoon JANG ; Han Koo KIM ; Woo Seob KIM ; Tae Hui BAE
Archives of Aesthetic Plastic Surgery 2018;24(1):39-41
Ectropion is characterized by eversion of the eyelid margin and exposure of the cornea and conjunctiva. This leaves the inner eyelid surface exposed and prone to irritation, and in severe cases, poor eye closure. Ectropion can occur for several reasons including congenital malformations, trauma, burns, anti-cancer medications, allergies, and inappropriate eyelid surgery. Surgical treatments usually include local flaps or skin grafts, depending on the severity of the defect. We present a case of successful cicatricial upper eyelid ectropion correction using a dermofat graft and an anti-adhesive agent (Guardix-Sol) after the wide release of tethering scar tissue.
Burns
;
Cicatrix
;
Conjunctiva
;
Cornea
;
Ectropion
;
Eyelids
;
Hypersensitivity
;
Skin
;
Transplants
6.Safety and Efficacy of Ziagen (Abacavir Sulfate) in HIV-Infected Korean Patients.
Heawon ANN ; Ki Hyon KIM ; Hyun Young CHOI ; Hyun Ha CHANG ; Sang Hoon HAN ; Kye Hyung KIM ; Jin Soo LEE ; Yeon Sook KIM ; Kyung Hwa PARK ; Young Keun KIM ; Jang Wook SOHN ; Na Ra YUN ; Chang Seop LEE ; Young Wha CHOI ; Yil Seob LEE ; Shin Woo KIM
Infection and Chemotherapy 2017;49(3):205-212
BACKGROUND: Abacavir is a widely-used nucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus (HIV) infection. Mandatory postmarketing surveillance was conducted in Korea to monitor the safety and evaluate the effectiveness of Ziagen® (abacavir sulfate 300 mg; ViiV Healthcare, Middlesex, UK). MATERIALS AND METHODS: An open-label, multi-center, non-interventional postmarketing surveillance study was conducted from June 2010 to June 2016 to monitor the safety and effectiveness of Ziagen across 12 hospitals in Korea. Subjects older than 18 years taking Ziagen according to prescribing information were enrolled. The primary outcome was defined as the occurrence of any adverse events after Ziagen administration. Secondary outcomes included the occurrence of adverse drug reactions, occurrence of serious adverse events, and effectiveness of Ziagen administration. RESULTS: A total of 669 patients were enrolled in this study, with a total observation period of 1047.8 person-years. Of these, 90.7% of patients were male. The mean age of patients was 45.8±11.9 years. One-hundred ninety-six (29.3%) patients reported 315 adverse events, and four patients reported seven serious adverse events, without any fatal events. There was one potential case of an abacavir hypersensitivity reaction. Among the 97 adverse drug reactions that were reported from 75 patients, the most frequent adverse drug reactions included diarrhea (12 events), dyspepsia (10 events), and rash (9 events). No ischemic heart disease was observed. In the effectiveness analysis, 91% of patients achieved HIV-1 RNA under 50 copies/mL after 24 months of observation with abacavir administration. CONCLUSION: Our data showed the safety and effectiveness of Ziagen in a real-world setting. During the study period, Ziagen was well-tolerated, with one incident of a clinically suspected abacavir hypersensitivity reaction. The postmarketing surveillance of Ziagen did not highlight any new safety information. These data may be helpful in understanding abacavir and the HIV treatment practices in Korea.
Delivery of Health Care
;
Diarrhea
;
Drug-Related Side Effects and Adverse Reactions
;
Dyspepsia
;
Exanthema
;
HIV
;
HIV-1
;
Humans
;
Hypersensitivity
;
Korea
;
Male
;
Myocardial Ischemia
;
Pharmacoepidemiology
;
RNA
;
RNA-Directed DNA Polymerase
7.Current Advances in Three-Dimensional Tissue/Organ Printing.
Jeong Hun PARK ; Jinah JANG ; Jung Seob LEE ; Dong Woo CHO
Tissue Engineering and Regenerative Medicine 2016;13(6):612-621
Three-dimensional (3D) tissue/organ printing is a major aspect of recent innovation in the field of tissue engineering and regenerative medicine. 3D tissue/organ printing aims to create 3D living tissue/organ analogues, and have evolved along with advances in 3D printing techniques. A diverse range of computer-aided 3D printing techniques have been applied to dispose living cells together with biomaterials and supporting biochemical factors within pre-designed 3D tissue/organ analogues. Recent developments in printable biomaterials, such as decellularized extracellular matrix bio-inks have enabled improvements in the functionality of the resulting 3D tissue/organ analogues. Here, we provide an overview of the 3D printing techniques and biomaterials that have been used, including the development of 3D tissue/organ analogues. In addition, in vitro models are described, and future perspectives in 3D tissue/organ printing are identified.
Biocompatible Materials
;
Extracellular Matrix
;
In Vitro Techniques
;
Printing, Three-Dimensional
;
Regenerative Medicine
;
Tissue Engineering
8.Erratum: A FEM study on stress distribution of tooth-supported and implant-supported overdentures retained by telescopic crowns.
Chang Gyu LEE ; Jang Hyun PAEK ; Tae Hun KIM ; Min Jung KIM ; Hyeong Seob KIM ; Kung Rock KWON ; Yi Hyung WOO
The Journal of Korean Academy of Prosthodontics 2012;50(3):218-218
There has been a mistake, claimed and confirmed by all the authors of Vol 50(1), 2012, p10-20 issue, that first author should have been Chang-Gyu Lee instead of Jang-Hyun Paek.
9.A FEM study on stress distribution of tooth-supported and implant-supported overdentures retained by telescopic crowns.
Jang Hyun PAEK ; Chang Gyu LEE ; Tae Hun KIM ; Min Jung KIM ; Hyeong Seob KIM ; Kung Rock KWON ; Yi Hyung WOO
The Journal of Korean Academy of Prosthodontics 2012;50(1):10-20
PURPOSE: The purpose of this study was to investigate the stress distribution in mandibular implant-supported overdentures and tooth-supported overdentures with telescopic crowns. MATERIALS AND METHODS: The assumption of this study was that there were 2, 3, 4 natural teeth and implants which are located in the second premolar and canine regions in various distributed conditions. The mandible, teeth (or implants and abutments), and connectors are modeled, and analyzed with the commercial software, ANSYS Version 10.1. Stress distribution was evaluated under 150 N vertical load bilaterally on 3 experimental conditions - between canine areas, canine and 2nd premolars, 10 mm posterior to 2nd premolars. RESULTS: Overall, the case of the implant group showed more stress than the case of the teeth group in stress distribution to bone. In stress distribution to superstructures of tooth and implants, there was no significant difference between TH group and IM group and the highest stress appeared in TH-IV and IM-IV. The stress caused from bar was much higher than those of implant and tooth. TH group showed less stress than IM group in stress distribution to abutment teeth and implant. CONCLUSION: The results shows that it is crucial to make sure that distance between impact loading point and abutment tooth does not get too far apart, and if it does, it is at best to set abutment tooth on premolar tooth region. It will be necessary to conduct more experiments on effects on implants, natural teeth and bone, in order to apply these results to a clinical treatment.
Bicuspid
;
Crowns
;
Denture, Overlay
;
Mandible
;
Tooth
10.Pak1/LIMK1/Cofilin Pathway Contributes to Tumor Migration and Invasion in Human Non-Small Cell Lung Carcinomas and Cell Lines.
Inseok JANG ; Byeong Tak JEON ; Eun Ae JEONG ; Eun Jin KIM ; Dawon KANG ; Jong Sil LEE ; Baek Geun JEONG ; Jin Hyun KIM ; Bong Hoi CHOI ; Jung Eun LEE ; Jong Woo KIM ; Jun Young CHOI ; Gu Seob ROH
The Korean Journal of Physiology and Pharmacology 2012;16(3):159-165
Squamous cell carcinoma (SCC) and adenocarcinoma (AC) are the major histological types of non-small cell lung carcinoma (NSCLC). Although both SCCs and ACs have been characterized histologically and clinically, the precise mechanisms underlying their migration and invasion are not yet known. Here, we address the involvement in NSCLC of the p21-associated kinase1 (Pak1)/LIM kinase1 (LIMK1)/cofilin pathway, which recently has been reported to play a critical role in tumor migration and invasion. The Pak1/LIMK1/cofilin pathway was evaluated in tumors from SCC (n=35) and AC (n=35) patients and in SCC- and AC-type cell lines by western blotting, immunohistochemistry, and in vitro migration and invasion assays. The levels of phosphorylated Pak1, LIMK1, and cofilin in lung tumor tissues from SCC patients were increased as compared to normal tissues. In addition, immunohistochemistry showed greater expression of phosphorylated cofilin in SCC tissues. Expression of phosphorylated Pak1 and LIMK1 proteins was also significantly higher in SCC-type cells than in AC-type cells. Moreover, migration and invasion assays revealed that a higher percentage of SCC type cells exhibited migration and invasion compared to AC type cells. Migration was also decreased in LIMK1 knockdown SK-MES-1 cells. These findings suggest that the activation of the Pak1/LIMK1/cofilin pathway could preferentially contribute to greater tumor migration and invasion in SCC, relative to that in AC.
Adenocarcinoma
;
Blotting, Western
;
Carcinoma, Squamous Cell
;
Cell Line
;
Humans
;
Immunohistochemistry
;
Lung
;
Lung Neoplasms
;
Proteins

Result Analysis
Print
Save
E-mail